C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/53 (2006.01) A61P 25/00 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2657594
The invention provides compounds of formula I [INSERT CHEMICAL STRUCTURE HERE] (I) and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
La présente invention concerne des composés répondant à la formule I [INSÉRER LA FORMULE CHIMIQUE À CET ENDROIT] (I) et leurs sels pharmaceutiquement acceptables. Les composés répondant à la formule I inhibent l'activité tyrosine kinase et se révèlent de ce fait utiles en tant qu'agents anticancéreux et pour le traitement de la maladie d'Alzheimer.
Frennesson David B.
Johnson Walter Lewis
Langley David R.
Liu Peiying
Mastalerz Harold
Bristol-Myers Squibb Company
Gowling Lafleur Henderson Llp
LandOfFree
Pyrrolotriazine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolotriazine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolotriazine kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1457410